내시경 점막하 박리술은 소화관(특히 식도, 위, 대장)에 생긴 종양과 병변을 절제하는 데 사용되는 낮은 침습 수술 절차입니다.
일반의 수술과 달리 내시경 점막하 박리술은 내시경을 사용하여 종양을 심층 조직별로 완전히 절제할 수 있습니다. 이 절차는 카메라가 있는 가늘고 플렉서블 튜브(내시경)를 환자의 소화관에 삽입하여 비정상적인 증식과 병변을 확인하고 관찰합니다.
치료하는 동안 의사는 특수 도구를 사용하여 점막하(소화관 내벽의 가장 안쪽에있는 점막 아래에 위치한 조직층)를 박리하여 표적 병변을 절제합니다. 그 때 주위의 정상 조직은 가능한 한 온존합니다. 내시경 점막하 박리술은 조기 암이나 폴리펙토미와 같은 다른 내시경 접근법에 적합하지 않은 큰 표재성 종양의 치료에 특히 효과적입니다.
이 절차의 큰 장점 중 하나는 더 침습적인 수술을 필요로하지 않고 종양을 정확하게 절제할 수 있다는 것입니다. 따라서 회복 시간이 짧고 통증이 적고 흉터도 최소화할 수 있습니다. 또한 소화관의 기능을 온존할 수 있기 때문에 특정 유형의 암이나 양성 병변을 가진 많은 환자에게 선호되는 옵션이 되고 있습니다. 그러나 이 기술은 고급 기술과 전문 지식이 필요하며 일반적으로 전문 의료 센터에서 수행됩니다.
시장의 주요 성장 요인 중 하나는 식도암, 위암, 대장암을 포함한 소화관 암 증가입니다. 이러한 암은 종종 조기 병변으로 발견되며 내시경 점막하 박리술로 치료할 수 있습니다. 이 낮은 침습 절차는 종양을 대량 절제할 수 있고, 재발 위험을 줄이고, 보다 침습적인 수술의 필요성을 감소시킵니다.
소화관 암의 발생률 상승은 건강에 해로운 식생활, 앉기 쉬운 생활 습관, 고령화 등의 요인에 기인하고 있으며, 소화기 질환의 증례가 대폭 증가하고 있습니다. 이러한 질병은 종종 진행 단계에서 진단되기 때문에 조기 발견과 조기 개입의 중요성이 점점 증가하고 있습니다.
또한 내시경 기술의 발전, 예를 들어 고성능 이미지 시스템과 전기 수술 기구의 개선은 절차의 안전성과 효율성을 높이고 시장 수요를 뒷받침하고 있습니다. 또한 장기기능을 온존하고 회복을 가속화할 수 있는 저침습치료에 대한 기호의 고조도 시장성장에 기여하고 있습니다.
이러한 점으로부터, 소화관암 증가, 내시경 기술의 진보, 저침습 치료로의 시프트가, 내시경 점막하 박리술 시장 성장을 크게 견인하는 요인이 되고 있습니다.
본 보고서에서는 세계의 내시경 점막하 박리술 시장을 조사했으며, 주요 동향, 시장영향인자 분석, 법규제 환경, 기술·특허 분석, 시장 규모 추이와 예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요기업 프로파일 등을 정리했습니다.
Endoscopic submucosal dissection is a minimally invasive surgical technique used to remove tumors or lesions from the gastrointestinal (GI) tract, particularly in the esophagus, stomach, and colon. Unlike traditional surgical methods, endoscopic submucosal dissection allows for the complete resection of tumors, including deeper layers of tissue, using an endoscope. The procedure involves the insertion of a thin, flexible tube with a camera (endoscope) into the patient's digestive tract, where it enables surgeons to locate and visualize abnormal growths or lesions.
During the procedure, the surgeon uses specialized tools to dissect the submucosal layer (the layer of tissue beneath the mucosa, or the innermost lining of the GI tract) and remove the targeted lesion, while preserving the surrounding healthy tissue. endoscopic submucosal dissection is particularly effective for treating early-stage cancers and large, superficial tumors that may not be suitable for other endoscopic methods, such as polypectomy.
One of the primary advantages of endoscopic submucosal dissection is that it allows for precise removal of tumors without the need for more invasive surgeries, thus offering faster recovery times, less pain, and minimal scarring. Additionally, it helps in preserving the function of the GI tract, making it a preferred option for many patients with certain types of cancer or benign lesions. However, the procedure requires high skill and expertise and is typically performed in specialized medical centers.
One of the key drivers of the Endoscopic submucosal dissection market is the increasing prevalence of gastrointestinal (GI) cancers, including esophageal, gastric, and colorectal cancers. These cancers often present as early-stage lesions that are amenable to treatment through endoscopic submucosal dissection, a minimally invasive procedure that allows for the en-bloc resection of tumors, reducing the risk of recurrence and the need for more invasive surgeries.
This rising incidence of GI cancers is attributed to factors such as unhealthy dietary habits, sedentary lifestyles, and an aging population, which have significantly increased the cases related to gastrointestinal diseases. As these diseases are often diagnosed at advanced stages, there is a growing emphasis on early detection and intervention.
The demand for endoscopic submucosal dissection procedures is further bolstered by advancements in endoscopic technology, such as improved imaging systems and electrosurgical tools, which enhance the safety and efficacy of the procedure. Additionally, the preference for minimally invasive treatments, which offer benefits like reduced recovery times and preservation of organ function, is contributing to the market's growth.
In summary, the increasing prevalence of gastrointestinal cancers, coupled with technological advancements in endoscopic procedures and a shift towards minimally invasive treatments, are pivotal factors driving the growth of the Endoscopic submucosal dissection market.
Despite the growth of the Endoscopic submucosal dissection market, several challenges persist. One of the primary challenges is the high level of technical expertise required to perform the procedure successfully. endoscopic submucosal dissection is a complex and delicate procedure that demands specialized skills and extensive experience. The risk of complications, such as bleeding or perforation, is higher compared to other less invasive techniques, and improper execution can lead to poor patient outcomes. As a result, the procedure is generally limited to specialized centers with highly trained endoscopists, restricting its availability and limiting its adoption in regions with fewer trained professionals.
Another challenge is the high cost of the procedure, which involves advanced endoscopic equipment, including specialized knives and electrosurgical tools. The need for sophisticated imaging systems, such as high-definition or high-magnification endoscopes, adds to the cost of endoscopic submucosal dissection. Additionally, the procedure often requires longer hospital stays and follow-up care, further increasing the financial burden on healthcare systems and patients.
Finally, patient selection is also a challenge. While endoscopic submucosal dissection is effective for early-stage gastrointestinal cancers, not all patients are suitable candidates. Factors like the size, location, and depth of the lesion, as well as the patient's overall health, can influence the success of the procedure. These limitations mean that endoscopic submucosal dissection may not be viable for all gastrointestinal tumors, and other treatments may be required, reducing the overall demand for this technique.
The global Endoscopic submucosal dissection market is highly competitive, with major players such as Olympus Corporation, Fujifilm Holdings Corporation, Boston Scientific Corporation, Medtronic, Sumitomo Bakelite Co., Ltd., Creo Medical Group PLC, Hoya Corporation, Conmed Corporation, Steris PLC, MTW Endoskopie Manufaktur, Ovesco Endoscopy AG, Zeon Medical Inc., Micro-Tech Endoscopy, Karl Storz SE & Co. KG, and Cook Medical leading the charge.
These companies play a crucial role in driving innovation and offering a wide range of advanced endoscopic equipment, tools, and technologies that enhance the safety, precision, and effectiveness of endoscopic submucosal dissection procedures. They are actively focusing on technological advancements such as improved imaging systems, electrosurgical tools, and robotics, which have significantly contributed to the growing adoption of endoscopic submucosal dissection as a minimally invasive treatment for gastrointestinal cancers. With ongoing product development and strategic partnerships, these companies are set to maintain their leadership positions in the market and contribute to the continued growth of the endoscopic submucosal dissection industry.
Endoscopic submucosal dissection Market Segmentation:
Segmentation 1: by Product
Segmentation 2: by Indication
Segmentation 3: by End User
Segmentation 4: by Region
One of the most significant emerging trends in the global Endoscopic submucosal dissection market is the integration of robotic assistance and artificial intelligence (AI) into endoscopic submucosal dissection procedures. Robotic systems are enhancing the precision and control of surgeons, particularly in complex cases with large or challenging lesions.
These systems provide increased maneuverability and accuracy, allowing for more effective and safer dissections. Additionally, AI technologies are being incorporated to assist in lesion detection, characterization, and real-time guidance during procedures. AI-powered tools help endoscopists identify abnormalities more accurately, potentially reducing the risk of missed diagnoses and improving patient outcomes.
These advancements in robotics and AI are revolutionizing the endoscopic submucosal dissection field by improving precision, minimizing complications, and making the procedure more accessible, ultimately contributing to the continued growth and adoption of endoscopic submucosal dissection in gastrointestinal cancer treatment.
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note